Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
3.000
-0.080 (-2.60%)
At close: May 30, 2025, 4:00 PM
2.900
-0.100 (-3.33%)
After-hours: May 30, 2025, 7:35 PM EDT
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $514.33 million as of May 30, 2025. Its market cap has decreased by -39.08% in one year.
Market Cap
514.33M
Enterprise Value
-148.86M
1-Year Change
-39.08%
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $514.33M, a decrease of -83.05%. That is a compound annual growth rate of -30.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 514.33M | -25.42% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | 3.73B | 22.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 648.68B |
| Johnson & Johnson | 369.52B |
| AbbVie | 327.88B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 270.48B |
| Abbott Laboratories | 231.14B |
| Novartis AG | 219.70B |
| AstraZeneca | 216.88B |